E3 Ligase Engineering & Production Services

Name: E3 Ligase Engineering and Production
Brand: BOC Sciences

E3 ubiquitin ligases are the central specificity determinants in targeted protein degradation, responsible for recruiting substrates to the ubiquitin-proteasome system. The success of PROTAC design services, molecular glue programs, and emerging degrader modalities depends critically on the availability of well-characterized, functionally validated E3 ligases. BOC Sciences provides end-to-end E3 ligase engineering and production services, from construct design and expression optimization to purification, complex assembly, and functional characterization. Our capabilities span bacterial, mammalian, and insect cell expression systems, enabling us to produce both single-subunit E3 ligases and multi-component Cullin-RING complexes with the quality required for structural biology, biochemical assay development, and degrader screening campaigns.

Request a Consultation Explore Services

Services

BOC Sciences E3 Ligase Engineering and Production Capabilities

E3 Ligase Construct Design and Engineering We design expression constructs based on the target E3 ligase architecture, domain boundaries, and intended application. Our scientists analyze protein topology reports, disorder predictions, and homologous structure alignments to select optimal construct boundaries, enabling soluble expression while preserving catalytic activity and binding interfaces.
Recombinant E3 Ligase Expression and Production BOC Sciences produces recombinant E3 ligases across multiple expression hosts, including Escherichia coli, HEK293, CHO, and Sf9/insect cell systems. Expression conditions are screened and optimized for each target, taking into account codon usage, folding requirements, post-translational modifications, and complex assembly needs.
Domain, Tag, and Stability Optimization Solubility and stability are common challenges for E3 ligase production. We apply systematic tag screening, including polyhistidine, GST, MBP, SUMO, streptavidin-binding peptide, and general epitope tag options, together with domain truncation strategies, surface mutation engineering, and buffer formulation optimization to improve protein behavior without compromising functional integrity.
E3 Ligase Variant Characterization and Functional Validation Each produced E3 ligase undergoes rigorous quality assessment, including purity analysis by SDS-PAGE and analytical SEC, identity confirmation by mass spectrometry, and functional validation through activity assays. We confirm ubiquitination activity, substrate recruitment capability, and degrader-dependent ternary complex formation.

Ligase Systems

E3 Ligase Classes and Targets We Support

CRBN, VHL, IAP, and MDM2 Ligase Systems These four E3 ligases represent the most widely recruited systems in targeted protein degradation research. BOC Sciences produces full-length and domain-optimized variants of cereblon (CRBN), the von Hippel-Lindau protein (VHL), inhibitor of apoptosis proteins (IAPs), and MDM2, together with their essential interaction partners and adaptor components required for functional assays. CRBN and CRBN-DDB1 complexes VHL-Elongin B-Elongin C complexes IAP BIR domain constructs and full-length variants MDM2 RING domain and substrate-binding constructs
Cullin-RING Ligase Complexes and Adaptor Proteins Many E3 ligases function as part of multi-subunit Cullin-RING ligase (CRL) complexes. We engineer and produce Cullin scaffolds (Cul1, Cul2, Cul3, Cul4A, Cul4B, Cul5), RING-box proteins (Rbx1, Rbx2), and substrate receptor subunits, enabling reconstitution of intact CRL complexes for mechanistic and screening applications. Cullin scaffold proteins and neddylation variants Skp1-F-box, Elongin B/C-SOCS box, and BTB adaptor modules Substrate receptor subunits for targeted recruitment studies Nedd8-conjugated and unneddylated complex forms
RING, HECT, and RBR E3 Ligases Beyond the CRL superfamily, we support production of RING-type, HECT-domain, and RBR-family E3 ligases. These enzymes follow distinct catalytic mechanisms and offer expanding opportunities for tissue-specific and pathway-selective targeted protein degradation strategies. RING-family: TRIMs, c-Cbl, XIAP, and related proteins HECT-domain: NEDD4 family, SMURFs, E6AP, and others RBR-family: Parkin, HOIP, HHARI, and related enzymes Catalytic domain constructs and full-length variants
Emerging and Non-Canonical E3 Ligases for TPD Research The degradation field is actively exploring new E3 ligases to overcome limitations of current recruiting systems. BOC Sciences produces emerging targets including DCAF15, DCAF16, FEM1B, KEAP1, FBXO22, and other non-canonical E3 ligases, supporting ligand discovery and degrader platform development beyond established systems. DCAF15, DCAF16, and related DDB1-Cul4 associated factors FEM1B, KLHDC2, and C-terminal rule pathway ligases KEAP1, SIAH1/2, and stress-responsive E3 ligases Custom requests for literature-validated or proprietary targets

Need Custom-Engineered E3 Ligases for Your Degrader Program?

From construct design to functional validation, we deliver E3 ligases tailored to your assay, structural, and screening requirements.

Get a Quote

Platforms

Expression Platforms for E3 Ligase Production

Bacterial Expression Platform Our E. coli expression platform is optimized for catalytic domains, RING domains, and well-folded E3 ligase fragments. We offer multiple bacterial strain options, including standard expression strains, codon-supplemented strains, and disulfide bond-enhancing strains, together with temperature and induction screening and chaperone co-expression to improve soluble yields of challenging targets. High-throughput expression screening in 96-well format Chaperone co-expression using folding-assistance systems Periplasmic and cytoplasmic expression strategies Auto-induction and fed-batch fermentation options
Mammalian Cell Expression System HEK293 and CHO cells support production of full-length E3 ligases, post-translationally modified variants, and multi-subunit complexes that require eukaryotic folding machinery. This system is particularly suitable for VHL-Elongin complexes, IAP proteins, and Cullin-RING ligases requiring neddylation. Transient and stable expression in HEK293 and CHO lines Multi-gene co-expression for complex assembly Secreted and intracellular production formats Scalable suspension culture from milligram to gram quantities
Insect Cell (Baculovirus) Expression Platform The baculovirus-insect cell system provides a balance between eukaryotic folding capacity and production scalability. It is ideal for large E3 ligase complexes, membrane-associated components, and proteins requiring specific post-translational modifications not achievable in bacteria. Bacmid and baculovirus generation and titration Multi-gene baculovirus for co-expression applications Sf9, Sf21, and other insect cell line options Infection condition optimization for maximal soluble yield
Purification and Refolding Capabilities We apply affinity chromatography, ion exchange, size exclusion, and mixed-mode purification strategies tailored to each E3 ligase target. For proteins produced as inclusion bodies, our refolding platform uses systematic buffer screening to recover active conformation. IMAC, GST, streptavidin-binding peptide-based, and epitope tag-based affinity purification Analytical and preparative SEC for monodispersity assessment Inclusion body solubilization and refolding optimization Buffer exchange, tag removal, and formulation services

Advantages

Why Custom E3 Ligase Engineering Matters for Targeted Protein Degradation?

Expanding Degrader Design Space Beyond Standard Ligases

The majority of PROTACs and molecular glues recruit a limited set of E3 ligases. Access to a broader repertoire of engineered E3 ligases enables exploration of novel recruiter chemistry, reduces competition with endogenous substrates, and opens new tissue-specific degradation opportunities.

Enabling Tissue-Specific and Selective Degradation

Different E3 ligases show distinct expression patterns across tissues and cell types. Custom production of tissue-restricted or conditionally active E3 ligases supports development of degrader systems with improved selectivity profiles and reduced off-target liabilities.

Supporting Mechanistic and Structural Biology Studies

Well-characterized, high-quality E3 ligases are essential for structural determination, ternary complex characterization, and mechanism-of-action studies. Custom engineering enables production of stabilized variants, catalytically inactive mutants, and complex-specific constructs optimized for crystallography, cryo-EM, or NMR.

Accelerating Assay Development and Screening

Reliable E3 ligase reagents are the foundation of robust biochemical and cell-based degradation assays. Custom-produced ligases with validated activity reduce assay variability, improve data quality, and enable transfer of assays across different research stages.

Workflow

Our E3 Ligase Engineering and Production Workflow

01

Project Requirement and Ligase Biology Review

We begin by understanding your target E3 ligase, intended application, complex composition requirements, and assay format. Our team reviews available structural data, expression literature, and domain architecture to establish a realistic project scope and feasibility assessment.

02

Construct Strategy and Expression Feasibility Assessment

Based on bioinformatics analysis, we propose construct boundaries, tag configurations, expression hosts, and co-expression strategies. A feasibility report summarizes expected challenges, alternative approaches, and recommended production conditions.

03

Clone Design, Expression Screening, and Condition Optimization

Gene synthesis, codon optimization, and vector construction are followed by small-scale expression screening across multiple hosts and conditions. Promising leads are scaled up with optimized induction, temperature, and co-factor supplementation strategies.

04

Purification, Complex Assembly, and Buffer Optimization

Target proteins are purified using affinity, ion exchange, and size exclusion chromatography. Multi-subunit complexes are assembled stepwise or co-expressed, followed by buffer optimization to maximize stability, solubility, and activity retention.

05

Functional Testing and Data Interpretation

Purified E3 ligases undergo functional validation, including auto-ubiquitination assays, substrate ubiquitination activity, and degrader-dependent ternary complex formation. Activity data is interpreted in the context of your specific assay or screening requirements.

06

Report Delivery and Next-Step Optimization Guidance

BOC Sciences delivers a comprehensive report covering construct details, expression conditions, purification parameters, quality analysis, and functional assay results. We provide recommendations for scale-up, complex reconstitution, or further engineering if needed.

Accelerate Your Degrader Program with Engineered E3 Ligases

Partner with BOC Sciences for reliable E3 ligase production tailored to your discovery and screening needs.

Talk to Experts

Why Us

Why Choose BOC Sciences for E3 Ligase Engineering and Production?

Comprehensive E3 Ligase Coverage

We support production of major degradation-relevant E3 ligases (CRBN, VHL, IAP, MDM2), Cullin-RING complexes, RING/HECT/RBR families, and emerging non-canonical targets, providing a one-stop resource for diverse degrader programs.

Multi-Host Expression Expertise

Our bacterial, mammalian, and insect cell platforms allow rational matching of expression system to protein requirements. Complex multi-subunit assemblies benefit from host-specific folding and modification capabilities unavailable in single-system approaches.

Integrated Quality and Activity Validation

Every delivered E3 ligase is supported by purity data, identity confirmation, and functional activity results. This integrated validation approach ensures your reagents perform as expected in downstream assays and structural studies.

Flexible Scale and Customization

From milligram-scale assay reagents to larger batches for screening campaigns, we adapt production scale to your project stage. Custom construct modifications, tag configurations, and complex compositions are accommodated on request.

Applications

Applications of E3 Ligase Engineering and Production

PROTAC and Molecular Glue Degrader Development

Custom-produced E3 ligases enable characterization of degrader-induced ternary complexes, evaluation of ubiquitination efficiency, and comparison of recruiter-dependent degradation profiles across different ligase systems.

Novel E3 Ligase Ligand Discovery

Access to well-characterized E3 ligases supports fragment screening, hit validation, and ligand optimization for emerging or underexploited ligase targets, expanding the chemical toolbox available for degrader design.

Ternary Complex and Target Engagement Studies

Engineered E3 ligases are essential reagents for studying ternary complex formation, binding cooperativity, and residence time effects. Stabilized or catalytically inactive variants enable specific mechanistic questions to be addressed.

Ubiquitination Mechanism Research

Purified E3 ligases support in vitro ubiquitination assays, chain topology analysis, and kinetic studies that advance fundamental understanding of substrate recognition, transfer mechanisms, and regulatory factors.

E3 Ligase Selectivity and Substrate Recognition Studies

Comparative analysis of E3 ligase panels helps identify substrate specificity determinants, neo-substrate liabilities, and cell-type-dependent degradation behaviors, supporting rational recruiter selection in degrader programs.

Assay Reagent Preparation for Screening Campaigns

High-quality, batch-consistent E3 ligase reagents are prepared for biochemical assays, biophysical measurements, and high-throughput screening formats, ensuring reliable performance across multi-week or multi-site campaigns.

Case Study

Case Studies: Engineering Functional E3 Ligases for Degrader Programs

Project Background

A North American pharmaceutical research team was developing a panel of molecular glues targeting a Cullin-RING ligase substrate receptor for oncology applications. Their program required milligram quantities of a fully assembled CRL complex containing a specific Cullin scaffold, Rbx1, and the substrate receptor subunit. Previous attempts to produce the complex in-house had resulted in aggregation, poor stability, and loss of neddylation-dependent activity, blocking their assay development timeline.

Technical Challenges

The substrate receptor subunit contained significant intrinsically disordered regions that promoted aggregation when expressed alone. The Cullin scaffold required co-expression with Rbx1 and neddylation enzymes for proper activation. The full complex was unstable under standard purification conditions and lost activity within 48 hours of storage, making it unsuitable for extended screening campaigns.

BOC Sciences Solutions

Construct Boundary Optimization: We analyzed the substrate receptor domain architecture and designed three N-terminal and C-terminal truncation variants, identifying a construct that retained substrate-binding capability while eliminating the most disordered regions responsible for aggregation.
Co-Expression Strategy Development: The Cullin scaffold and Rbx1 were co-expressed in HEK293 cells with co-transfected neddylation enzymes, while the optimized substrate receptor was produced separately in insect cells and assembled in vitro with the neddylated Cullin-RING module.
Stabilization and Formulation: Systematic buffer screening identified a glycerol-containing formulation with optimized salt concentration and reducing agent that extended complex stability from 48 hours to over 14 days at -80℃ with minimal activity loss after freeze-thaw cycles.

Project Outcomes

BOC Sciences delivered 25 mg of functionally active CRL complex with greater than 90% purity, enabling the client to complete a 6-week molecular glue screening campaign with stable assay performance.

Project Background

A European biotechnology company was optimizing a series of BRD4-targeting PROTACs that recruited VHL as the E3 ligase. Their medicinal chemistry team needed a reliable, batch-consistent source of the VHL-Elongin B-Elongin C (VBC) complex for binding affinity measurement, ternary complex formation assays, and comparative evaluation of recruiter analogs. Commercially available VHL preparations showed inconsistent complex assembly and variable activity across batches.

Technical Challenges

The VBC complex requires precise stoichiometry between VHL, Elongin B, and Elongin C for stable assembly. The hydroxyproline modification at VHL residue 154 is critical for target recognition, and unmodified VHL showed markedly reduced binding to BRD4 PROTACs. The client required a preparation that maintained consistent hydroxyproline content and complex integrity across multiple production batches.

BOC Sciences Solutions

Co-Expression in Mammalian Cells: We designed a tricistronic expression vector encoding VHL, Elongin B, and Elongin C with optimized linker sequences, enabling balanced co-expression in HEK293 cells and efficient complex assembly during purification.
Hydroxyproline Validation: Mass spectrometry analysis confirmed hydroxyproline modification at the expected position, and we established a quality control threshold requiring greater than 85% modification content for batch release.
Binding and Complex Integrity Assays: Each batch was tested by analytical SEC for complex monodispersity, by SPR for PROTAC binding affinity, and by a ternary complex formation assay using BRD4 and a representative PROTAC to confirm functional integrity.

Project Outcomes

BOC Sciences delivered 12 mg of qualified VBC complex with consistent hydroxyproline modification, supporting comparative evaluation of 18 BRD4 PROTAC analogs and reliable ternary complex analysis.

Frequently Asked Questions (FAQ)

Frequently Asked Questions

Still have questions?

Contact Us

Why are E3 ligases critical in degrader discovery?

E3 ligases determine whether a target protein can be recruited into the ubiquitin-proteasome system and marked for degradation. In PROTAC, molecular glue, and other targeted protein degradation programs, the selected E3 ligase influences ternary complex formation, ubiquitination efficiency, substrate selectivity, and cell-context activity. A poorly assembled or inactive E3 ligase reagent can generate misleading biochemical data, even when the degrader itself is well designed. Functional E3 ligase proteins allow researchers to evaluate binding, recruitment, ubiquitination, and degrader mechanism with greater confidence during discovery-stage optimization.

Which E3 ligases support PROTAC research?

Common E3 ligases used in PROTAC research include CRBN, VHL, IAP, and MDM2 systems, while newer and less explored E3 ligases are increasingly investigated for tissue-relevant or target-specific degradation strategies. The best ligase choice depends on ligand availability, expression profile, target compatibility, ternary complex formation, and whether the ligase can be produced in a functional recombinant format. BOC Sciences supports both established and emerging E3 ligase systems by designing expression constructs, producing recombinant proteins or complexes, and validating their suitability for binding, ubiquitination, and degrader mechanism studies.

What makes E3 ligase production challenging?

E3 ligases are often difficult to produce because many contain flexible regions, multiple domains, zinc-binding motifs, substrate-recognition surfaces, or essential partner proteins. Some ligases lose activity when truncated incorrectly, while others require co-expression with adaptor proteins or scaffold components to form stable complexes. Multi-component Cullin-RING ligases are especially challenging because the final reagent depends on correct stoichiometry, assembly, folding, and buffer conditions. Effective production therefore requires more than a standard expression workflow. It requires construct engineering, host selection, purification optimization, complex assembly, and activity-linked characterization.

How is engineered E3 ligase activity validated?

Engineered E3 ligases can be evaluated through a combination of quality assessment and functional testing. Protein identity, apparent molecular weight, homogeneity, aggregation state, and stability are first checked using analytical methods such as SDS-PAGE, mass spectrometry, SEC, and thermal stability analysis. Functional validation may include ligand binding, adaptor interaction, substrate recognition, E2-E3 pairing, auto-ubiquitination, and substrate ubiquitination assays. For PROTAC research, degrader-induced ternary complex formation can also be tested. BOC Sciences integrates these readouts to determine whether an engineered ligase variant is suitable for downstream assay development.

How does BOC Sciences customize E3 ligase projects?

BOC Sciences customizes E3 ligase engineering and production projects according to the ligase class, target application, required protein format, complex composition, expression difficulty, and downstream assay plan. Our scientists can compare full-length proteins, truncated domains, tag configurations, host systems, co-expression strategies, and buffer conditions to identify a practical production route. For degrader programs, the service can be connected with binding assays, ternary complex analysis, ubiquitination studies, and variant characterization. This integrated approach helps clients obtain functional E3 ligase reagents that fit their specific PROTAC, molecular glue, or ubiquitination research needs.

Testimonials

Client Testimonials on E3 Ligase Engineering and Production

Support for Difficult E3 Ligase Production

"Our team struggled with a poorly soluble E3 ligase domain for several months. BOC Sciences redesigned the construct panel, compared expression hosts, and delivered a workable protein format that finally supported our biochemical assay development."

— Dr. Lawson, Discovery Biology Lead at a US Biotechnology Company

Recommendations for Construct Engineering

"The most helpful part was not just protein production. Their scientists explained why specific truncations, tags, and co-expression partners were selected, which helped our internal team understand the ligase system more clearly."

— Dr. Becker, Senior Scientist at a European Pharmaceutical Research Group

Expertise in Functional Validation

"We needed confidence that the purified ligase complex was active, not just visible on a gel. BOC Sciences connected production with binding and ubiquitination readouts, which made the reagent much more useful for our degrader program."

— Dr. Reid, Protein Sciences Director at an Oncology-Focused Biotech

Support for PROTAC Discovery Projects

"Their VHL complex production and assay guidance helped us interpret weak ternary complex data in our PROTAC series. The project saved us from discarding compounds that were actually limited by reagent quality."

— Ms. Fischer, Project Manager at a UK-Based Drug Discovery Organization